Key regions: Germany, United States, India, Japan, United Kingdom
The demand for Anti-Rheumatic Drugs in Angola has been steadily increasing over the years with a notable growth rate in the last two years.
Customer preferences: Angolan customers are showing a preference for biologic drugs that have been proven to be more effective in treating rheumatoid arthritis. The trend is driven by growing awareness and increased availability of biologic drugs in the market. Additionally, there is a preference for drugs that are easily accessible and affordable.
Trends in the market: The Anti-Rheumatic Drugs market in Angola is expected to grow due to the increasing prevalence of rheumatoid arthritis and other autoimmune diseases. The market is also expected to see growth in the use of biosimilars, which are cheaper alternatives to biologic drugs. The trend is driven by the need to reduce the cost of treatment and increase accessibility to essential drugs. The government's efforts to improve the healthcare system and increase access to healthcare services are also expected to drive the growth of the Anti-Rheumatic Drugs market in Angola.
Local special circumstances: Angola has a high prevalence of rheumatoid arthritis, which is one of the leading causes of disability in the country. The disease affects people of all ages, with women being more affected than men. The high prevalence of rheumatoid arthritis is attributed to a combination of genetic and environmental factors, including infections, lifestyle, and diet. The country's healthcare system is also underdeveloped, with limited access to essential drugs and healthcare services, which makes it difficult for patients to receive the necessary treatment.
Underlying macroeconomic factors: The Angolan economy has been experiencing a slowdown due to the decline in oil prices, which is the country's main source of revenue. The economic slowdown has had a negative impact on the healthcare system, with limited funding for healthcare services and infrastructure. The government has been implementing measures to diversify the economy and reduce dependence on oil, which is expected to improve the healthcare system in the long term. Additionally, the government has been working to improve access to essential drugs and healthcare services, which is expected to drive the growth of the Anti-Rheumatic Drugs market in Angola.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
